2VYA
Crystal Structure of fatty acid amide hydrolase conjugated with the drug-like inhibitor PF-750
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | APS BEAMLINE 23-ID-D |
Synchrotron site | APS |
Beamline | 23-ID-D |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2008-03-06 |
Detector | MARRESEARCH |
Spacegroup name | P 32 2 1 |
Unit cell lengths | 103.690, 103.690, 253.870 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | 38.260 - 2.750 |
R-factor | 0.191 |
Rwork | 0.188 |
R-free | 0.23900 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 1mt5 |
RMSD bond length | 0.012 |
RMSD bond angle | 1.585 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Phasing software | PHASER |
Refinement software | REFMAC (5.2.0019) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 40.000 | 2.850 |
High resolution limit [Å] | 2.750 | 2.750 |
Rmerge | 0.140 | 0.560 |
Number of reflections | 40178 | |
<I/σ(I)> | 7 | 2.1 |
Completeness [%] | 95.6 | 98.6 |
Redundancy | 3 | 3 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | 5.5 | PEG 400 10% NACL 100MM MES 100MM PH 5.5 |